OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Help
Advanced
Search
18
Results
Show all
Save search
Copy query
Show results for
Genomics
(15)
Unknown
(3)
Organisms
Homo sapiens
(15)
Repository
EGA
(15)
Technology Type
Illumina 15K
(8)
Illumina_670k - Illuminus, Affymetrix 6.0, Illumina 1.2M
(1)
Publication Date
Release Date
2016
(1)
2015
(1)
2007
(1)
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
Association of Vitamin D Levels With Outcome in Patients With Melanoma After Adjustment For C-Reactive Protein.
Not available
S-EPMC4966337
|
biostudies-literature
Cite
C-reactive protein as a marker of melanoma progression.
Not available
S-EPMC4397281
|
biostudies-literature
Cite
ATD
WTCCC1 project Autoimmune Thyroid Disease (ATD) samples
EGAD00000000011
|
EGA
Cite
WTCCC case-control study for Autoimmune Thyroid Disease - Combined Controls
WTCCC genome-wide case-control association study for Autoimmune Thyroid Disease (ATD) - Combined Controls.
EGAS00000000021
|
EGA
Cite
WTCCC case-control study for Autoimmune Thyroid Disease
WTCCC genome-wide case-control association study for Autoimmune Thyroid Disease (ATD) using the 1958 British Birth Cohort collection as controls.
EGAS00000000020
|
EGA
Cite
AS
WTCCC2 project samples from Ankylosing spondylitis Cohort
EGAD00010000150
|
EGA
Cite
Genomewide association studies in ankylosing spondylitis
The aim of this study was to identify genes associated with ankylosing spondylitis susceptibility in British and Australian individuals of European descent.
EGAS00000000104
|
EGA
Cite
BC
WTCCC1 project Breast cancer (BC) samples
EGAD00000000013
|
EGA
Cite
MS
WTCCC1 project Multiple Sclerosis (MS) samples
EGAD00000000012
|
EGA
Cite
WTCCC2 Ankylosing spondylitis cases - individual
WTCCC1 project Ankylosing Spondylitis (AS) samples
EGAD00000000010
|
EGA
Cite
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets